Correlation Between 26444HAL5 and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both 26444HAL5 and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 26444HAL5 and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DUK 3 15 DEC 51 and Apogee Therapeutics, Common, you can compare the effects of market volatilities on 26444HAL5 and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 26444HAL5 with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of 26444HAL5 and Apogee Therapeutics,.

Diversification Opportunities for 26444HAL5 and Apogee Therapeutics,

0.1

Correlation Coefficient

26444HAL5  Apogee Therapeutics,

Average diversification

The 3 months correlation between 26444HAL5 and Apogee is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding DUK 3 15 DEC 51 and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and 26444HAL5 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DUK 3 15 DEC 51 are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of 26444HAL5 i.e., 26444HAL5 and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between 26444HAL5 and Apogee Therapeutics,

Assuming the 90 days trading horizon DUK 3 15 DEC 51 is expected to generate 0.27 times more return on investment than Apogee Therapeutics,. However, DUK 3 15 DEC 51 is 3.66 times less risky than Apogee Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  6,206  in DUK 3 15 DEC 51 on December 24, 2024 and sell it today you would earn a total of  221.00  from holding DUK 3 15 DEC 51 or generate 3.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	60.66%
Values	Daily Returns

DUK 3 15 DEC 51  vs.  Apogee Therapeutics, Common

26444HAL5

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DUK 3 15 DEC 51 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 26444HAL5 may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with 26444HAL5 and Apogee Therapeutics,

The main advantage of trading using opposite 26444HAL5 and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 26444HAL5 position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind DUK 3 15 DEC 51 and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.